On the public citation graph

Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043

0 signed · 80 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 28 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-04): 10.1074/jbc.m503111200 (notice 2020-09-11).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/emmm.201303575openalex-snapshot
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
inferredcites →https://doi.org/10.1016/j.bmc.2008.07.070openalex-snapshot
Quantitative structure–activity relationship studies on nitrofuranyl anti-tubercular agents
inferredcites →https://doi.org/10.1016/j.bmc.2012.08.023openalex-snapshot
Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties
inferredcites →https://doi.org/10.1016/j.bmcl.2007.09.048openalex-snapshot
Discovery of novel isoxazolines as anti-tuberculosis agents
inferredcites →https://doi.org/10.1016/j.tube.2010.09.001openalex-snapshot
Leads for antitubercular compounds from kinase inhibitor library screens
inferredcites →https://doi.org/10.1016/s0022-5347(06)00427-7openalex-snapshot
RNA Interference-Directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity In Vivo
inferredcites →https://doi.org/10.1016/s1359-6446(04)03199-xopenalex-snapshot
The Organic Chemistry of Drug Design and Drug Action
inferredcites →https://doi.org/10.1017/s0022172400061349openalex-snapshot
Mycobacterium marinuminfections in man
inferredcites →https://doi.org/10.1021/cb300151mopenalex-snapshot
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
inferredcites →https://doi.org/10.1021/ja311058qopenalex-snapshot
Thiolates Chemically Induce Redox Activation of BTZ043 and Related Potent Nitroaromatic Anti-Tuberculosis Agents
inferredcites →https://doi.org/10.1021/jm0306430openalex-snapshot
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy
inferredcites →https://doi.org/10.1021/jm030644sopenalex-snapshot
Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening
inferredcites →https://doi.org/10.1021/jm050765nopenalex-snapshot
Synthesis and Evaluation of Cyclic Secondary Amine Substituted Phenyl and Benzyl Nitrofuranyl Amides as Novel Antituberculosis Agents
inferredcites →https://doi.org/10.1021/ml500039gopenalex-snapshot
Design and Syntheses of Anti-Tuberculosis Agents Inspired by BTZ043 Using a Scaffold Simplification Strategy
inferredcites →https://doi.org/10.1038/35016103openalex-snapshot
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
inferredcites →https://doi.org/10.1073/pnas.0508392103openalex-snapshot
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1074/jbc.m503111200openalex-snapshot
RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo
inferredcites →https://doi.org/10.1084/jem.97.5.695openalex-snapshot
STUDIES ON THE PROPAGATION IN VITRO OF POLIOMYELITIS VIRUSES
inferredcites →https://doi.org/10.1093/jnci/51.5.1409openalex-snapshot
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
inferredcites →https://doi.org/10.1126/science.1171583openalex-snapshot
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
inferredcites →https://doi.org/10.1126/scitranslmed.3004395openalex-snapshot
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1177/1352458513501572openalex-snapshot
Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing–remitting multiple sclerosis
inferredcites →https://doi.org/10.1208/s12248-008-9017-8openalex-snapshot
Pharmacokinetically-Guided Lead Optimization of Nitrofuranylamide Anti-Tuberculosis Agents
inferredcites →https://doi.org/10.1371/journal.pmed.0030466openalex-snapshot
OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice
inferredcites →https://doi.org/10.1371/journal.pone.0026675openalex-snapshot
Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis
inferredcites →https://doi.org/10.1371/journal.ppat.1000645openalex-snapshot
High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
inferredcites →https://doi.org/10.20506/rst.20.1.1265openalex-snapshot
The mycobacteria: an introduction to nomenclature and pathogenesis
inferredcites →https://doi.org/10.2174/156802607780059772openalex-snapshot
Nitrofurans as Novel Anti-tuberculosis Agents: Identification, Development and Evaluation

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4622835openalex-extracted
inferred← citeshttps://doi.org/10.1002/adsc.201801221openalex-snapshot
Domino Reactions Initiated by Copper‐Catalyzed Aryl‐I Bond Thiolation For the Switchable Synthesis of 2,3‐Dihydrobenzothiazinones and Benzoisothiazolones
inferred← citeshttps://doi.org/10.1002/adsc.202301504openalex-snapshot
Synthesis of Benzo[e][1,3]thiazin‐4‐ones via PPh3‐Promoted Cyclization of Benzo[c][1,2]dithiol‐3‐ones and Amidines
inferred← citeshttps://doi.org/10.1002/ajoc.201800587openalex-snapshot
Dehydrative C‐ and S‐Alkylation: Access to Highly Substituted 1‐Sulfonylpropanes
inferred← citeshttps://doi.org/10.1002/ardp.202300356openalex-snapshot
Design and synthesis of benzofuran‐ and naphthalene‐fused thiazinones as antimycobacterial agents
inferred← citeshttps://doi.org/10.1002/cmdc.202100733openalex-snapshot
Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1002/cmdc.202200021openalex-snapshot
New Insight into Dearomatization and Decarbonylation of Antitubercular 4H‐Benzo[e][1,3]thiazinones: Stable 5H‐ and 7H‐Benzo[e][1,3]thiazines
inferred← citeshttps://doi.org/10.1002/cmdc.202300099openalex-snapshot
DprE1 Inhibitors: Enduring Aspirations for Future Antituberculosis Drug Discovery
inferred← citeshttps://doi.org/10.1002/ddr.21921openalex-snapshot
Recent advancement in drug development of nitro( NO2 )‐heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1002/slct.202004156openalex-snapshot
Molecular Insight into the Discrepancy of Antitubercular Activity between 8‐Nitro and 8‐Cyano Benzothiazinones
inferred← citeshttps://doi.org/10.1002/slct.202505382openalex-snapshot
Preclinical and Clinical Efficacy of Promising DprE1 Inhibitors: A Critical Review
inferred← citeshttps://doi.org/10.1007/978-3-031-15955-8_24openalex-snapshot
Exploring Decaprenylphosphoryl-β-d-Ribose 2′-Epimerase 1 (DprE1): A Target for Anti-tubercular Drugs
inferred← citeshttps://doi.org/10.1007/978-981-99-8339-1_15openalex-snapshot
Treatment of Drug-Resistant Pulmonary Tuberculosis
inferred← citeshttps://doi.org/10.1007/s00044-020-02676-4openalex-snapshot
8-cyanobenzothiazinone analogs with potent antitubercular activity
inferred← citeshttps://doi.org/10.1016/j.apsb.2022.04.014openalex-snapshot
Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.01.115openalex-snapshot
Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities
inferred← citeshttps://doi.org/10.1016/j.bmc.2017.05.037openalex-snapshot
Novel pyridyl nitrofuranyl isoxazolines show antibacterial activity against multiple drug resistant Staphylococcus species
inferred← citeshttps://doi.org/10.1016/j.bmc.2023.117212openalex-snapshot
Targeting mycobacterial membranes and membrane proteins: Progress and limitations
inferred← citeshttps://doi.org/10.1016/j.bmcl.2016.11.084openalex-snapshot
Recent advancements in the development of anti-tuberculosis drugs
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.03.020openalex-snapshot
Drug discovery in tuberculosis. New drug targets and antimycobacterial agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.03.060openalex-snapshot
Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.09.042openalex-snapshot
Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.111595openalex-snapshot
Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113603openalex-snapshot
Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115976openalex-snapshot
Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation
inferred← citeshttps://doi.org/10.1016/j.ijleo.2021.167383openalex-snapshot
Temperature effects on liquid crystal-based tunable biosensors
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119301openalex-snapshot
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs
inferred← citeshttps://doi.org/10.1016/j.tet.2025.134676openalex-snapshot
TfOH-catalyzed PPh3-promoted nucleophilic cyclization reactions for the synthesis of functionalized (Z)-2-imino-benzo[e][1,3]thiazin-4-ones
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00098openalex-snapshot
Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00281openalex-snapshot
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis
inferred← citeshttps://doi.org/10.1021/acs.joc.4c01310openalex-snapshot
Synthesis of 5-Trifluoromethyl-1,3-thiazin-4-one Compounds using Trifluoromethyl Acrylic Acid as a Synthon
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.2c00215openalex-snapshot
BTZ-Derived Benzisothiazolinones with In Vitro Activity against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1021/acsomega.2c05307openalex-snapshot
Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis : Computational Analysis of Physicochemical and ADMET Properties
inferred← citeshttps://doi.org/10.1021/acssuschemeng.5b01784openalex-snapshot
Facile Sulfa-Michael Reactions with Sodium Arylsulfinates in Water: The Promotion of Water on the Reaction
inferred← citeshttps://doi.org/10.1038/ja.2017.126openalex-snapshot
New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development
inferred← citeshttps://doi.org/10.1039/c5md00394fopenalex-snapshot
Endless resistance. Endless antibiotics?
inferred← citeshttps://doi.org/10.1039/c7md00528hopenalex-snapshot
Narrow-spectrum antibacterial agents
inferred← citeshttps://doi.org/10.1039/c7ob02101aopenalex-snapshot
Double 1,4-addition of (thio)salicylamides/thiosalicylic acids with propiolate derivatives: a direct, general synthesis of diverse heterocyclic scaffolds
inferred← citeshttps://doi.org/10.1039/d0ra00750aopenalex-snapshot
Identification of benzothiazones containing a hexahydropyrrolo[3,4- c ]pyrrol moiety as antitubercular agents against MDR-MTB
inferred← citeshttps://doi.org/10.1039/d1ce00346aopenalex-snapshot
A systematic investigation on the impact of the level of oxidation at sulfur and the configuration of R / S -sulfoxide on the solid structure
inferred← citeshttps://doi.org/10.1039/d1qo00147gopenalex-snapshot
Transition metal-free and solvent-free calcium carbide promotes the formation of β-keto sulfoxide from acyl chloride and DMSO
inferred← citeshttps://doi.org/10.1039/d3cc00356fopenalex-snapshot
Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones
inferred← citeshttps://doi.org/10.1080/00397911.2026.2669989openalex-snapshot
Synthesis and cyclization of benzo[ c ][1,2]dithiol-3-ones
inferred← citeshttps://doi.org/10.1080/07391102.2023.2230312openalex-snapshot
Structure-activity relationship mediated molecular insights of DprE1 inhibitors: A Comprehensive Review
inferred← citeshttps://doi.org/10.1080/08927022.2019.1659507openalex-snapshot
Decoding the signature of molecular mechanism involved in mutation associated resistance to 1, 3-benzothiazin-4-ones (Btzs) based DprE1 inhibitors using BTZ043 as a reference drug
inferred← citeshttps://doi.org/10.1080/17460441.2022.2103535openalex-snapshot
The piperazine scaffold for novel drug discovery efforts: the evidence to date
inferred← citeshttps://doi.org/10.1107/s2053229620010931openalex-snapshot
Crystallographic evidence for unintended benzisothiazolinone 1-oxide formation from benzothiazinones through oxidation
inferred← citeshttps://doi.org/10.1107/s2414314620016636openalex-snapshot
N-[2-(3,4-Dimethoxyphenyl)-2-(phenylsulfanyl)ethyl]-2-(2-fluorophenyl)acetamide
inferred← citeshttps://doi.org/10.21292/2075-1230-2022-100-5-64-70openalex-snapshot
DprE1 inhibitors – a prospective target for development of antituberculosis drugs
inferred← citeshttps://doi.org/10.2174/1389557518666181015151801openalex-snapshot
Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones
inferred← citeshttps://doi.org/10.2174/1568026619666190305130809openalex-snapshot
4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB
inferred← citeshttps://doi.org/10.3390/ph19050707openalex-snapshot
Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.